<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34414665</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.</ArticleTitle><Pagination><StartPage>1563</StartPage><EndPage>1572</EndPage><MedlinePgn>1563-1572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.509</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to describe complications occurring after COVID-19 in this group of patients.</AbstractText><AbstractText Label="METHODS">A prospective single-center cohort study was conducted at University Hospital Centre Zagreb. Patients with two negative reverse transcriptase-polymerase chain reaction (RT-PCR) tests for SARS-CoV-2 after COVID-19 were eligible for further follow-up at our outpatient clinic. They underwent detailed clinical and laboratory assessments. The primary outcome was the development of complications after COVID-19.</AbstractText><AbstractText Label="RESULTS">Only 11.53% of renal transplant recipients who survived acute COVID-19 were symptomless and free from new-onset laboratory abnormalities during the median follow-up of 64 days (range: 50-76 days). Three patients died from sepsis after discharge from the hospital. In 47 patients (45.2%), clinical complications were present, while 74 patients (71.2%) had one or more laboratory abnormalities. The most common clinical complications included shortness of breath (19.2%), tiredness (11.5%), peripheral neuropathy (7.7%), self-reported cognitive impairments (5.7%), and dry cough (7.7%). Most common laboratory abnormalities included shortened activated partial thromboplastin time (50%), elevated D-dimers (36.5%), elevated fibrinogen (30.16%), and hypogammaglobulinemia (24%). Positive RT-PCR for cytomegalovirus (8.7%), Epstein-Barr virus (26%), or BK virus (16.3%). Multivariate analysis identified the history of diabetes mellitus and eGFR CKD-EPI as predictors for the development of post-COVID clinical complications. Six months after acute COVID-19, elevated D-dimers persisted with normalization of other laboratory parameters. Twenty-nine patients were hospitalized, mostly with several concomitant problems. However, initially reported clinical problems gradually improved in the majority of patients.</AbstractText><AbstractText Label="CONCLUSION">Post-COVID-19 clinical and laboratory complications are frequent in the renal transplant population, in some of them associated with significant morbidity. All patients recovered from acute COVID-19 should undergo long-term monitoring for evaluation and treatment of complications.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Basic-Jukic</LastName><ForeName>Nikolina</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0221-2758</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juric</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furic-Cunko</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katalinic</LastName><ForeName>Lea</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radic</LastName><ForeName>Josipa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Clinical Hospital Centre Split and Faculty of Medicine, University of Split, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosnjak</LastName><ForeName>Zrinka</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Microbiology, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jelakovic</LastName><ForeName>Bojan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kastelan</LastName><ForeName>Zeljko</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, Clinical Hospital Centre Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">renal transplantation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>7</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34414665</ArticleId><ArticleId IdType="pmc">PMC8426882</ArticleId><ArticleId IdType="doi">10.1002/iid3.509</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27:601&#x2010;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID&#x2010;19 in a multistate health care systems network&#x2014;United States, March&#x2010;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2010;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post&#x2010;discharge persistent symptoms and health&#x2010;related quality of life after hospitalization for COVID&#x2010;19. J Infect. 2020 Dec;81(6):e4&#x2010;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324:603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O'Brien K, et al. Persistent poor health post&#x2010;COVID&#x2010;19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18:1431&#x2010;1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513647</ArticleId><ArticleId IdType="pubmed">33596163</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3&#x2005;months after a SARS&#x2010;CoV&#x2010;2 infection: the post&#x2010;COVID&#x2010;19 syndrome? ERJ Open Res. 2020;6:542&#x2010;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradian ST, Parandeh A, Khalili R, Karimi L. Delayed symptoms in patients recovered from COVID&#x2010;19. Iran J Public Health. 2020;49(11):2120&#x2010;2127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917497</ArticleId><ArticleId IdType="pubmed">33708732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingasivam V, Craik A, Tomlinson LA, et al. A systematic review of COVID&#x2010;19 and kidney transplantation. Kidney Int Rep. 2021;6(1):24&#x2010;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607258</ArticleId><ArticleId IdType="pubmed">33163708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair V, Jandovitz N, Hirsch JS, et al. COVID&#x2010;19 in kidney transplant recipients. Am J Transplant. 2020;20(7):1819&#x2010;1825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267603</ArticleId><ArticleId IdType="pubmed">32351040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira MR, Mohan S, Cohen DJ, et al. COVID&#x2010;19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20(7):1800&#x2010;1808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264777</ArticleId><ArticleId IdType="pubmed">32330343</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbrands LB, Duivenvoorden R, Vart P, et al. COVID&#x2010;19&#x2010;related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020;35(11):1973&#x2010;1983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665620</ArticleId><ArticleId IdType="pubmed">33151337</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfishawy M, Elbendary A, Mohamed M, Nassar M. COVID&#x2010;19 Mortality in Transplant Recipients. Int J Organ Transplant Med. 2020;11(4):145&#x2010;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726838</ArticleId><ArticleId IdType="pubmed">33335696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk S, Turgutalp K, Arici M, et al. Mortality analysis of COVID&#x2010;19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020;35(12):2083&#x2010;2095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716804</ArticleId><ArticleId IdType="pubmed">33275763</ArticleId></ArticleIdList></Reference><Reference><Citation>Adapa S, Chenna A, Balla M, et al. COVID&#x2010;19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation. J Clin Med Res. 2020;12(6):352&#x2010;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295554</ArticleId><ArticleId IdType="pubmed">32587651</ArticleId></ArticleIdList></Reference><Reference><Citation>Cravedi P, Mothi SS, Azzi Y, et al. COVID&#x2010;19 and kidney transplantation: results from the TANGO International Transplant Consortium. Am J Transplant. 2020;20(11):3140&#x2010;3148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405285</ArticleId><ArticleId IdType="pubmed">32649791</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;Ruiz M, Andr&#xe9;s A, Loinaz C, et al. COVID&#x2010;19 in solid organ transplant recipients: a single&#x2010;center case series from Spain. Am J Transplant. 2020;20(7):1849&#x2010;1858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9800471</ArticleId><ArticleId IdType="pubmed">32301155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kates OS, Haydel BM, Florman SS, et al. COVID&#x2010;19 in solid organ transplant: a multi&#x2010;center cohort study. Clin Infect Dis. 2020:ciaa1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias M, Pievani D, Randoux C, et al. COVID&#x2010;19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31(10):2413&#x2010;2423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7609004</ArticleId><ArticleId IdType="pubmed">32847984</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DR &amp; Snell EJ. Analysis of Binary Data. Vol 32. Monographs on Statistics and Applied Probability. London; 1989.</Citation></Reference><Reference><Citation>Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78:691&#x2010;692.</Citation></Reference><Reference><Citation>Al&#x2010;Otaibi TM, Gheith OA, Abuelmagd MM, et al. Better outcome of COVID&#x2010;19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression. Clin Transplant. 2021;25:e14297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250222</ArticleId><ArticleId IdType="pubmed">33768630</ArticleId></ArticleIdList></Reference><Reference><Citation>Akalin E, Azzi Y, Bartash R, et al. Covid&#x2010;19 and kidney transplantation. N Engl J Med. 2020;382(25):2475&#x2010;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200055</ArticleId><ArticleId IdType="pubmed">32329975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post&#x2010;COVID&#x2010;19 manifestations. Int J Clin Pract. 2020;75:e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J. Post&#x2010;COVID&#x2010;19 fatigue: potential contributing factors. Brain Sci. 2020;10(12):1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID&#x2010;19: Interim guidance on rehabilitation in the hospital and post&#x2010;hospital phase from a European Respiratory Society and American Thoracic Society&#x2010;coordinated International Task Force. Eur Respir J. 2020;56(6):2002197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres&#x2010;Castro R, Solis&#x2010;Navarro L, Sitj&#xe0;&#x2010;Rabert M, Vilar&#xf3; J. Functional limitations Post&#x2010;COVID&#x2010;19: a comprehensive assessment strategy. Arch Bronconeumol. 2021;57(suppl 1):7&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455248</ArticleId><ArticleId IdType="pubmed">34629627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Crewther S. Post&#x2010;COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci. 2020;419:117179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani RD, Dabas N, Goldberger JJ. COVID&#x2010;19 cardiac injury: implications for long&#x2010;term surveillance and outcomes in survivors. Heart Rhythm. 2020;17(11):1984&#x2010;1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad Alhiyari M, Ata F, Islam Alghizzawi M, et al. Post COVID&#x2010;19 fibrosis, an emerging complication of SARS&#x2010;CoV&#x2010;2 infection. IDCases. 2020;23:e01041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785952</ArticleId><ArticleId IdType="pubmed">33425682</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med. 2021;21(1):e63&#x2010;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, Malsy J, P&#xf6;ttgen J, et al. Frequent neurocognitive deficits after recovery from mild COVID&#x2010;19. Brain Commun. 2020;2(2):205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2010;6 months after COVID&#x2010;19 in non&#x2010;hospitalised subjects: a population&#x2010;based cohort study. Thorax. 2020;76(4):405&#x2010;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Zhang T, Zhu N, Han M. Characteristics of COVID&#x2010;19 patients with preexisting CKD history. Int Urol Nephrol. 2021;5:1&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935001</ArticleId><ArticleId IdType="pubmed">33674950</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;Zt&#xfc;rk S, Turgutalp K, Arici M, et al. Impact of hospital&#x2010;acquired acute kidney injury on Covid&#x2010;19 outcomes in patients with and without chronic kidney disease: a multicentre, retrospective cohort study. Turk J Med Sci. 2021;51:947&#x2010;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283512</ArticleId><ArticleId IdType="pubmed">33611868</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirim AB, Demir E, Yadigar S, et al. COVID&#x2010;19 in chronic kidney disease: a retrospective, propensity score&#x2010;matched cohort study. Int Urol Nephrol. 2021;6:1&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864795</ArticleId><ArticleId IdType="pubmed">33548044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Reis T, Husain&#x2010;Syed F. Management of acute kidney injury in patients with COVID&#x2010;19. Lancet Respir Med. 2020;8(7):P738&#x2010;P742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255232</ArticleId><ArticleId IdType="pubmed">32416769</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SE, Redeker A, Arens R, et al. CMV immune evasion and manipulation of the immune system with aging. GeroScience. 2017;39:273&#x2010;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505894</ArticleId><ArticleId IdType="pubmed">28647908</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales&#x2010;S&#xe1;nchez A, Fuentes&#x2010;Panana EM. The immunomodulatory capacity of an Epstein&#x2010;Barr virus abortive lytic cycle: potential contribution to viral tumorigenesis. Cancers. 2018;10(4):98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923353</ArticleId><ArticleId IdType="pubmed">29601503</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID&#x2010;19. J Thromb Haemost. 2020;18:1559&#x2010;1561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9770920</ArticleId><ArticleId IdType="pubmed">32302453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844&#x2010;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Favaloro EJ. D&#x2010;dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020;120:876&#x2010;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295300</ArticleId><ArticleId IdType="pubmed">32246450</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;Ortega A, de la Rosa D, Oscullo G, Castillo&#x2010;Villegas D, L&#xf3;pez&#x2010;Reyes R, Mart&#xed;nez&#x2010;Garc&#xed;a M&#xc1;. Coagulation disorders and thromboembolic disease in COVID&#x2010;19: review of current evidence in search of a better approach. J Thorac Dis. 2021;13(2):1239&#x2010;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947499</ArticleId><ArticleId IdType="pubmed">33717596</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose RJ, Manuel A. COVID&#x2010;19 cytokine storm: the interplay between inflammation and coagulation. Lancet. 2020;8(6):e46&#x2010;e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID&#x2010;19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241581</ArticleId><ArticleId IdType="pubmed">32440883</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos CG, Gravendeel J, Keller BPJA. Three cases of spontaneous major bleeding in patients with a COVID&#x2010;19 infection. Acta Chir Belg. 2021;26:1&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33769205</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanich X, Antol&#xed; A, Padull&#xe9;s N, et al. Pragmatic, open&#x2010;label, single&#x2010;center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID&#x2010;19: the TACROVID trial protocol. Contemp Clin Trials Commun. 2021;21:100716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817439</ArticleId><ArticleId IdType="pubmed">33495742</ArticleId></ArticleIdList></Reference><Reference><Citation>Karruli A, Spiezia S, Boccia F, et al. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID&#x2010;19: systematic review and meta&#x2010;analysis. Transpl Infect Dis. 2021;28:e13595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7995235</ArticleId><ArticleId IdType="pubmed">33641202</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi R, Kubo S, Ohta T, et al. FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. Cell Signal. 2013;25(9):1731&#x2010;1738.</Citation><ArticleIdList><ArticleId IdType="pubmed">23707520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidokoro K, Satoh M, Nagasu H, et al. Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change. Kidney Blood Press Res. 2012;35(6):549&#x2010;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>